|
Home
Table B29a. Recovery
(percent) of low-molecular-weight PAH analytes added to matrix spike
muscle composites |
Composite
# |
Station |
Naph-
thalene |
2-
methyl-
naph-
thalene |
1-
methyl-
naph-
thalene |
Biphenyl |
2,6-
dimethyl-
naph-
thalene |
Acenaph-
thylene |
Acenaph-
thene |
2,3,5-
trimethyl-
naph-
thalene |
Fluo-
rene |
Phen-
anthrene |
Anthra-
cene |
1-methyl-
phen-
anthrene |
|
107 |
BL2 |
26 |
38 |
41 |
39 |
46 |
42 |
45 |
49 |
43 |
71 |
58 |
85 |
|
117 |
FL2 |
15 |
22 |
22 |
25 |
28 |
29 |
30 |
38 |
39 |
48 |
60 |
63 |
|
127 |
FL6 |
28 |
32 |
32 |
33 |
36 |
37 |
37 |
41 |
43 |
52 |
59 |
63 |
|
138 |
SB3 |
40 |
46 |
46 |
46 |
47 |
52 |
46 |
46 |
44 |
59 |
65 |
63 |
|
146 |
TA1 |
30 |
36 |
36 |
39 |
42 |
44 |
44 |
47 |
47 |
62 |
68 |
70 |
|
156 |
TA3 |
22 |
27 |
27 |
31 |
33 |
35 |
33 |
40 |
35 |
32 |
40 |
53 |
Table B29b. Recovery
(percent) of high-molecular-weight PAH analytes added to matrix spike
muscle composites |
Composite
# |
Station |
Fluor-
anthene |
Pyrene |
Benz[a]-
anthra-
cene |
Chry-
sene |
Benzo[b]-
fluoran-
thene |
Benzo[k]-
fluoran-
thene |
Benzo[e]-
pyrene |
Benzo[a]-
pyrene |
Pery-
lene |
Indeno-
[1,2,3-
cd]-
pyrene |
Dibenz-
[a,h]anth-
racene |
Benzo-
[ghi]-
perylene |
|
107 |
BL2 |
88 |
82 |
52 |
50 |
19 |
18 |
17 |
12 |
7 |
30 |
22 |
28 |
|
117 |
FL2 |
69 |
71 |
101 |
90 |
76 |
76 |
62 |
47 |
1 |
32 |
26 |
21 |
|
127 |
FL6 |
64 |
64 |
87 |
77 |
73 |
72 |
67 |
42 |
1 |
55 |
38 |
36 |
|
138 |
SB3 |
69 |
70 |
104 |
88 |
69 |
69 |
57 |
58 |
40 |
34 |
23 |
26 |
|
146 |
TA1 |
73 |
75 |
107 |
94 |
93 |
91 |
79 |
73 |
50 |
82 |
69 |
65 |
|
156 |
TA3 |
60 |
46 |
50 |
43 |
28 |
29 |
23 |
24 |
22 |
14 |
10 |
11 |
Table B30
|